🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Missouri › Kansas City

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Kansas City, MO keessatti

Qorannoo 6 Kansaar Onnee Triple-Negative f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Saint Luke's Cancer Institute ( Site 0059), Kansas City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Kansas, Westwood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07020117

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Universtiy Health, Kansas City
  • KCCC South, Kansas City
  • Research Medical Center, Kansas City
  • fi 2 dabalataa
Umuriin hundi · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT02302742

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Kansas Medical Center (KUMC), Westwood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • The University of Kansas Hospital, Westwood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT06926920

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Kansas City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.